Advertisement

Saint John police issue warning after finding potent new opioid in the city

Saint John police are warning the public after officers say a potent new opioid was recently found in the city. The Canadian Press/Graeme Roy

The Saint John Police Force has issued a warning after finding a potent new synthetic opioid on city streets.

Police say the opioid was found during a recent investigation.

READ MORE: Nova Scotia law would reserve province’s right to sue over opioid damages

The police force has now confirmed the pill to be isotonitazene, an opioid the Center for Forensic Science Research and Education says has a potency similar to or greater than fentanyl.

According to police, the pill came in the form of a white triangular tablet with rounded corners. There was an “M” punched into one side of the pill and the number “8” on the other.

A photo of the isotonitazene pill found by the Saint John Police Force after an investigation.
A photo of the isotonitazene pill found by the Saint John Police Force after an investigation. Saint John Police Force-HO

Lab technicians with the Saint John Police Force say the substance is being presented in a way that could lead people to believe it was some other drug.

Story continues below advertisement

The police are now issuing a warning after their tests indicated that someone may need several doses of naloxone, a drug used to block the effects of opioids, to counter an overdose caused by isotonitazene.

Click to play video: 'Chief medical officer issues furanyl fentanyl warning after New Brunswick death'
Chief medical officer issues furanyl fentanyl warning after New Brunswick death

“Safety of the public, officers with the SJPF and our emergency personnel colleagues is continually paramount,” said Jim Hennessy, a spokesperson for the police force.

“By sharing this information, we are making the public and emergency personnel aware of a new drug that can have serious consequences if consumed or exposed to. The SJPF continually works to ensure this and other drugs are not readily available through ongoing investigations.”

Sponsored content

AdChoices